Author Question: Which of the following statements about disseminated intravascular coagulation (DIC) is TRUE? A) ... (Read 152 times)

ap345

  • Hero Member
  • *****
  • Posts: 537
Which of the following statements about disseminated intravascular coagulation (DIC) is TRUE?
 
  A) The bleeding typical of DIC is a result of an increased fibrinogen level.
  B) DIC most commonly results from hemophilia, hypertension, and severe tissue injury.
  C) Causes of DIC include reduced fibrinogen levels, consumption of coagulation factors, and thrombocytopenia.
  D) Activated thrombin converts fibrinogen to fibrin in the circulating blood.

Question 2

At 0330, you responded to the scene of an overturned tanker truck. What organization could you contact to obtain information about the liquid the truck is carrying?
 
  A) CHEMTREC B) Environmental Protection Agency (EPA)
  C) Regional poison control center D) CHEM-CALL


GCabra

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

D

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library